Analysis by SuperRatings has shown that paying attention to how your superannuation is invested pays dividends. SuperRatings has tracked the returns of the most common super options over the past 10 years with the results displayed in the chart below. SuperRatings Executive Director, Kirby Rappell, says “A balance of $100,000 in Nov 2011 invested in […]
SuperRatings is excited to announce its top-rated KiwiSaver schemes for 2022. The market continues to be extremely competitive, with fees and performance being key drivers of changes in ratings outcomes over the year. Eight providers were awarded a ‘Platinum’ rating for 2022. SuperRatings’ assessment criteria considers five key factors, including investments, fees, member servicing, scheme […]
October was another positive month for superannuation, as confidence was high, in anticipation of lockdowns lifting and the economy opening up further. According to SuperRatings’ data, the median balanced option rose an estimated 0.7% in October, with the median growth option rising by a similar amount. While the median capital stable option was flat returning […]
The assessment of performance of superannuation funds has gained traction over the past month, with the release of the government’s first superannuation performance test findings. When deciding to switch funds, it is easy to be swayed by investment returns, but there are other considerations that are as important. SuperRatings CEO Kirby Rappell says ‘Superannuation is […]
The 2021 financial year saw a rapid recovery from the economic downturn, followed by ongoing growth as confidence soared on the back of the development of COVID-19 vaccines. This led to the hope of a return to a more normal lifestyle, with superannuation funds riding the market highs to deliver some of the best returns […]
Superannuation funds are under increasing pressure to drive down fees. While investment fees and costs are a key driver of the amount members pay for their superannuation, demonstrating the relationship between cost and value remains challenging. SuperRatings has analysed how investment fees have changed since 2011. The chart below shows the median annual cost for […]
Super fund recovery maintains momentum May continues the recovery in superannuation with another month of steady performance figures, as confidence remained high despite lagging vaccinations and snap lockdowns. According to SuperRatings’ data, the median balanced option rose an estimated 1.1% in May, while the median growth option rose an estimated 1.3% and the median capital […]
With the recovery in superannuation looking increasingly secure, the focus in May was on the federal budget and some of the new measures to strengthen the system, including additional support to boost women’s retirement savings. This budget is the second pandemic budget, with the focus now shifting from temporary spending measures to building a more […]
The remarkable recovery in super fund’s performance continues with another strong month of returns despite a slower vaccine rollout than many had hoped for and some regulatory uncertainty around the use of some vaccines. According to SuperRatings data, the median balanced option rose an estimated 2.0% in March, while the median growth option rose an […]
A year on from the start of the COVID-19 pandemic, super funds continue to enjoy in the market recovery as vaccine rollouts and the return to more normal economic conditions lift confidence. Members have welcomed the return to a more stable footing, but markets are still more volatile compared to the pre-COVID-19 situation. Much also […]
Important information: Any express or implied rating or advice is limited to general advice, it doesn’t consider any personal needs, goals or objectives. Before making any decision about financial products, consider whether it is personally appropriate for you in light of your personal circumstances. Obtain and consider the Product Disclosure Statement for each financial product and seek professional personal advice before making any decisions regarding a financial product.